Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

B. Riley restated their buy rating on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. B. Riley currently has a ...

Stock analysts at Cantor Fitzgerald initiated coverage on shares of Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) in a ...

An aerial drone photo taken on March 19, 2025 shows buildings of the National Multimode Trans-Scale Biomedical Imaging Center ...

Sun Yujie (R), deputy dean of the College of Future Technology at Peking University, introduces the National Multimode ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...

Amy joined Editas two and a half years ago as our head of Finance, working closely with the CFO. Her track record of ...

VivoPower subsidiary, Caret Digital, to be spun off via a direct Nasdaq listingVivoPower shareholders as of a future record date, to receive 5 ...

KATHMANDU, March 22: Police have seized a large quantity of stolen mobile phones, laptops, and tablets and arrested seven ...

Reuters reported that President Trump’s tariffs have impacted the broader stock markets, weighing on investors’ sentiments, ...